Neose and BioGeneriX AG Announce Development and Marketing Agreement for GlycoPEGylated(TM) Next-Generation Protein
21-Apr-2004 -
Horsham, Pa., and Mannheim, Germany. Neose Technologies, Inc. and BioGeneriX AG, a company of the ratiopharm Group, today announced that they have signed an agreement to use Neose's proprietary GlycoPEGylation(TM) technology to develop a long-acting, next-generation version of granulocyte colony ...
biologics
Germany
Japan
+1